Egyptian Starch & Glucose
Egyptian Starch & Glucose operates in various business sectors.
Egyptian Starch & Glucose (ESGI) - Net Assets
Latest net assets as of : EGP- EGP
Based on the latest financial reports, Egyptian Starch & Glucose (ESGI) has net assets worth EGP- EGP as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (EGP-) and total liabilities (EGP-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | EGP- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Egyptian Starch & Glucose - Net Assets Trend (None–None)
This chart illustrates how Egyptian Starch & Glucose's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Egyptian Starch & Glucose (None–None)
The table below shows the annual net assets of Egyptian Starch & Glucose from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Egyptian Starch & Glucose's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Egyptian Starch & Glucose Competitors by Market Cap
The table below lists competitors of Egyptian Starch & Glucose ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kafr El Zayat Pesticides
EGX:KZPC
|
$1.79K |
|
Enzymatica AB
F:EN9
|
$1.79K |
|
Sardar Chemical Industries Ltd
KAR:SARC
|
$1.79K |
|
Kelyniam Global Inc
PINK:KLYG
|
$1.79K |
|
Dadex Eternit Ltd
KAR:DADX
|
$1.79K |
|
Song Hong Aluminum JSC
VN:NSH
|
$1.79K |
|
Emaar Misr for Development
EGX:EMFD
|
$1.79K |
|
SAFETY MEDICAL PROD
BE:S8M
|
$1.79K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Egyptian Starch & Glucose's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Egyptian Starch & Glucose's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Egyptian Starch & Glucose utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Egyptian Starch & Glucose's net assets metrics with peer companies in the same industry.
No peer company data available for comparison.